M&A Deal Summary

Johnson & Johnson Acquires Abiomed

On November 1, 2022, Johnson & Johnson acquired medical products company Abiomed for 16.6B USD

Acquisition Highlights
  • This is Johnson & Johnson’s 16th transaction in the Medical Products sector.
  • This is Johnson & Johnson’s 4th largest (disclosed) transaction.
  • This is Johnson & Johnson’s 34th transaction in the United States.
  • This is Johnson & Johnson’s 5th transaction in Massachusetts.

M&A Deal Summary
Date 2022-11-01
Target Abiomed
Sector Medical Products
Buyer(s) Johnson & Johnson
Deal Type Going Private
Deal Value 16.6B USD
Advisor(s) Goldman Sachs (Financial)
Sullivan & Cromwell (Legal)

Target

Abiomed

Danvers, Massachusetts, United States
Abiomed is a cardiovascular device company. Abiomed develops, manufactures, and markets medical products designed to establish recovery's as the standard of care for acute patients. Abiomed was formed in 1981 and is based in Danvers, Massachusetts.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Johnson & Johnson

New Brunswick, New Jersey, United States
Category Company
Founded 1886
Sector Consumer Products
Employees132,000
Revenue 85.2B USD (2023)
DESCRIPTION
Johnson & Johnson's corporate headquarters in New Brunswick, New Jersey.
Johnson & Johnson's corporate headquarters in New Brunswick, New Jersey.

Johnson & Johnson is a global healthcare conglomerate that operates across three primary sectors: Pharmaceuticals, Medical Devices, and Consumer Health. In Pharmaceuticals, it develops treatments for a variety of conditions, including immunology, oncology, and infectious diseases. The Medical Devices segment offers a range of equipment and devices for healthcare professionals, encompassing orthopedics, surgery, and cardiovascular care. Its Consumer Health division markets a wide array of products, spanning baby care, oral care, skin care, over-the-counter drugs, and women's health, with popular brands such as Band-Aid, Tylenol, and Neutrogena under its umbrella. Johnson & Johnson was formed in 1886 and is based in New Brunswick, New Jersey.

DEAL STATS #
Overall 41 of 45
Sector (Medical Products) 16 of 17
Type (Going Private) 1 of 1
State (Massachusetts) 5 of 5
Country (United States) 34 of 37
Year (2022) 1 of 1
Size (of disclosed) 4 of 29
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-08-19 Momenta Pharmaceuticals

Cambridge, Massachusetts, United States

Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the detailed structural analysis of complex drugs. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for oncology and autoimmune indications. Momenta Pharmaceuticals was founded in 2001 and is based in Cambridge, Massachusetts.

Buy $6.5B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-05-04 Kenvue

Skillman, New Jersey, United States

Kenvue is a global consumer goods and healthcare products company. Its brands include AVEENO, BAND-AID Brand Adhesive Bandages, JOHNSON’S, LISTERINE, NEUTROGENA, TYLENOL, and ZYRTEC, which are recommended by health care professionals. Kenvue was established in 2023 and is based in Skillman, New Jersey.

Sell -
Mergr

Product

Company

Legal